|
Apr 9
|
Why You Shouldn't Bet Against AnaptysBio (ANAB) Stock.
|
|
Mar 18
|
Industry Analysts Just Made A Stunning Upgrade To Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts
|
|
Mar 14
|
What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock
|
|
Mar 14
|
Wall Street Analysts Believe AnaptysBio, Inc. (ANAB) Could Rally 69.62%: Here's is How to Trade
|
|
Mar 14
|
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
|
|
Mar 11
|
AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates
|
|
Mar 11
|
Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
|
Feb 29
|
Analysts Estimate Lexicon Pharmaceuticals (LXRX) to Report a Decline in Earnings: What to Look Out for
|
|
Feb 29
|
Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting
|
|
Feb 28
|
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Jan 31
|
Anaptys to Present at Guggenheim’s 6th Annual Biotechnology Conference
|
|
Jan 13
|
AnaptysBio Inc CEO Daniel Faga Sells 6,866 Shares
|
|
Jan 9
|
Sarepta (SRPT) Rises on Solid Q4 and 2023 Preliminary Results
|
|
Jan 9
|
Corcept (CORT) Stock Rises on Upbeat Revenue Guidance for 2024
|
|
Jan 8
|
Are Medical Stocks Lagging Acadia Healthcare (ACHC) This Year?
|
|
Dec 27
|
AnaptysBio (NASDAQ:ANAB) shareholders have endured a 66% loss from investing in the stock five years ago
|
|
Dec 7
|
Does AnaptysBio, Inc. (ANAB) Have the Potential to Rally 69.36% as Wall Street Analysts Expect?
|
|
Nov 27
|
Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Portfolio from Centessa Pharmaceuticals
|
|
Nov 16
|
Revenue Downgrade: Here's What Analysts Forecast For AnaptysBio, Inc. (NASDAQ:ANAB)
|
|
Nov 14
|
Down -24.46% in 4 Weeks, Here's Why AnaptysBio, Inc. (ANAB) Looks Ripe for a Turnaround
|